Travoprost

Overview

Travoprost is a prostaglandin analog used for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It works by increasing the outflow of aqueous humor from the eyes.

API suppliers (12)

Suppliers of Travoprost backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• YS LIFE SCIENCE CO LTD1 active DMF
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• CAYMAN PHARMA SRO1 active DMF
• CAYMAN PHARMA SRO1 active DMF
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• YS LIFE SCIENCE CO LTD1 active DMF
• EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan
• Biocon LimitedIndia

Patent & exclusivity (US)

Per the FDA Orange Book (9 approved US products), the latest listed US patent on Travoprost expires 14 Feb 2031 and exclusivity 13 Dec 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas